Influenza vaccines
AssigneesInvVax, Inc., The Regents of the University of California
InventorsArthur Young, Ren Sun, Nicholas C. Wu
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions related to vaccines, e.g., influenza vaccines, including, peptide based vaccines, nucleic acid based vaccines, recombinant virus based vaccines, antibody based vaccines, and virus based vaccines. Also provided herein are methods related to vaccines, e.g., influenza vaccines, including methods of identifying epitopes for the vaccines, producing, formulating, and administering the vaccines.
Claims12
A polypeptide comprising influenza virus epitopes, wherein the polypeptide comprises the sequences of SEQ ID NOs:
- 2, 3, 8, 11, 12, 17, 21, 22, 24, 32, 33, 34, 40, 41, 43, 49, 51, 52, 58, 59, 61, 62, 70, 73, 74, 75, 76, 77, 78, 82, 84, 85, 86, 92, 93, and 94.
A polypeptide comprising influenza virus epitopes, wherein the polypeptide comprises:
- a first sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 8;
- a second sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 11;
- a third sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 12;
- a fourth sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 2;
- a fifth sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 3;
- a sixth sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 32;
- a seventh sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 24;
- an eighth sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 17;
- a ninth sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 29;
- and
- a tenth sequence comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 33.
A polypeptide comprising influenza virus epitopes, wherein the polypeptide comprises:
- at least 3 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 8;
- at least 3 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 11;
- at least 4 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 12;
- at least 2 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 2;
- at least 3 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 3;
- at least 4 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 32;
- at least 3 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 21;
- at least 3 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 24;
- at least 3 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 17;
- at least 5 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 29;
- and
- at least 8 sequences comprising at least 75% sequence identity to the sequence of SEQ ID NO:
- 33.
Dependencies are inferred from the claim text.